The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI US$ 26.19 Min. order: 1 piece ★★★★★ 5.0 (62 reviews) Sold : Login>>
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI US$ 29.27 Min. order: 1 piece ★★★★★ 5.0 (126 reviews) Sold : Login>>
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial US$ 24.85 Min. order: 1 piece ★★★★★ 4.1 (82 reviews) Sold : Login>>
FOXO4-DRI PEPTIDE 2MG/5MG/10MG VIAL – UMBRELLA Labs US$ 24.27 Min. order: 1 piece ★★★★★ 4.0 (287 reviews) Sold : Login>>
CagriSema vs Tirzepatide: 23% Weight Loss in Phase 3 Trial US$ 24.26 Min. order: 1 piece ★★★★★ 4.1 (296 reviews) Sold : Login>>
Weight Loss Efficacy of Cagrilintide and Semaglutide US$ 22.28 Min. order: 1 piece ★★★★★ 4.2 (82 reviews) Sold : Login>>